A financial incentive program for Pennsylvania emergency departments (EDs) to start medication-assisted treatment (MAT) for opioid addiction (OUD) modestly increased rates of buprenorphine treatment post-discharge among Medicaid beneficiaries.

Before participating in Pennsylvania’s Opioid Hospital Quality Improvement Program (O-HQIP) incentive program, hospitals saw a rate of 5% of opioid-related ED visitors filling a buprenorphine prescription. This increased to 7.6% after hospitals implemented the program. At hospitals that did not participate in the O-HQIP the post-ED-visit buprenorphine fill rate remained at about 5%.

O-HQIP started in 2020. It pays participating Pennsylvania hospitals . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.